Entos Pharmaceuticals Inc.
$764,000.00 CAD
≈ 10 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- November 3, 2025 – March 31, 2026
- Reference
- nrc-cnrc:172-2025-2026-Q3-1037546
Published purpose
Seasonal and pandemic influenza continue to pose substantial threats to public health and highly pathogenic strains such as H5N1 carry the potential for devastating outbreaks. The Firm proposes to develop a novel long-acting pre-exposure prophylaxis platform to deliver DNA-encoded broadly neutralizing antibodies directly to the upper and lower respiratory tracts. This approach aims to provide durable, broad-spectrum protection against influenza infection including emerging avian strains through a single inhaled or intranasal administration.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions